Literature DB >> 3467372

Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.

J Eid, R F Ebert, M S Gesell, J L Spivak.   

Abstract

In polycythemia vera, idiopathic myelofibrosis, and essential thrombocytosis, hematopoietic cell proliferation is increased in the absence of a recognizable stimulus, suggesting the autonomous production of growth factors in these disorders. Sonicates of peripheral blood mononuclear cells (PBMNC) from patients with polycythemia vera, idiopathic myelofibrosis, and essential thrombocytosis contained soluble factors that stimulated the proliferation of quiescent-confluent 3T3 cells. PBMNC sonicates from normal individuals; from patients with secondary erythrocytosis, chronic myelogenous leukemia, B-cell chronic lymphocytic leukemia, and acute myelogenous leukemia; and from K-562 and HL-60 cells did not stimulate proliferation. Polycythemia vera PBMNC sonicates also induced anchorage-independent colony formation in soft agar by normal rat kidney fibroblasts. Both the mitogenic and transforming activities of the polycythemia vera PBMNC sonicates resided in the T-lymphocyte-depleted mononuclear fraction of the PBMNC and were not secreted. By gel filtration, reversed-phase HPLC and NaDodSO4/PAGE, the mitogenic and transforming activities in the polycythemia vera PBMNC were localized to three proteins with molecular masses of 13-, 17-, and 65-kDa. The 13-kDa protein was only mitogenic, and the 17-kDa protein was only transforming, whereas the 65-kDa protein had both mitogenic and transforming activity. These proteins may be involved in the autonomous hematopoiesis that characterizes polycythemia vera, idiopathic myelofibrosis, and essential thrombocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3467372      PMCID: PMC304243          DOI: 10.1073/pnas.84.2.532

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  ARTERIAL STUDIES IN PRIMARY AND SECONDARY POLYCYTHEMIC DISORDERS.

Authors:  J F MURRAY
Journal:  Am Rev Respir Dis       Date:  1965-09

2.  Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components.

Authors:  A Vogel; E Raines; B Kariya; M J Rivest; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

4.  High-sensitivity sequence determination of proteins quantitatively recovered from sodium dodecyl sulfate gels using an improved electrodialysis procedure.

Authors:  A S Bhown; J E Mole; F Hunter; J C Bennett
Journal:  Anal Biochem       Date:  1980-03-15       Impact factor: 3.365

5.  Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  J Cell Physiol       Date:  1980-11       Impact factor: 6.384

6.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor.

Authors:  B M Martin; M A Gimbrone; E R Unanue; R S Cotran
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Polycythemia vera. Further in vitro studies of hematopoietic regulation.

Authors:  J W Adamson; J W Singer; P Catalano; S Murphy; N Lin; L Steinmann; C Ernst; P J Fialkow
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A.

Authors:  K C Glenn; R Ross
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

9.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera.

Authors:  C J Eaves; A C Eaves
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

10.  Transforming growth factor production by chemically transformed cells.

Authors:  H L Moses; E L Branum; J A Proper; R A Robinson
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  4 in total

1.  Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures.

Authors:  J D Cashman; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.

Authors:  A J Sytkowski; C O'Hara; G Vanasse; M J Armstrong; S Kreczko; N Dainiak
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Authors:  J C Keutzer; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

4.  Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.

Authors:  C H Dai; S B Krantz; R T Means; S T Horn; H S Gilbert
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.